Details for Patent: 12,370,179

Which drugs does patent 12,370,179 protect, and when does it expire?

Patent 12,370,179 protects MYQORZO and is included in one NDA.

This patent has twenty-five patent family members in twenty-three countries.

Summary for Patent: 12,370,179

Title:	Methods for treating hypertrophic cardiomyopathy
Abstract:	Methods for treating obstructive hypertrophic cardiomyopathy are described herein. The treatment methods include the administration of a cardiac myosin inhibitor (CK-3773274, also referred to as CK-274 or aficamten) and may include titrating an administrated daily dose based on one or more components of an echocardiogram. The daily dose may be increased, maintained, decreased, or terminated, based on the echocardiogram.
Inventor(s):	Fady Malik, Stuart Kupfer, Stephen B. Heitner, Laura Ann Robertson, Lixin Meng, Anna Osmukhina, Qi Wohltman
Assignee:	Cytokinetics Inc
Application Number:	US18/909,401
Patent Claim Types: see list of patent claims	Use; Device;

Drugs Protected by US Patent 12,370,179

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Cytokinetics	MYQORZO	aficamten	TABLET;ORAL	219083-001	Dec 19, 2025		RX	Yes	Yes	12,370,179					TREATMENT OF ADULTS WITH SYMPTOMATIC OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY (OHCM) TO IMPROVE FUNCTIONAL CAPACITY AND SYMPTOMS
Cytokinetics	MYQORZO	aficamten	TABLET;ORAL	219083-002	Dec 19, 2025		RX	Yes	No	12,370,179					TREATMENT OF ADULTS WITH SYMPTOMATIC OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY (OHCM) TO IMPROVE FUNCTIONAL CAPACITY AND SYMPTOMS
Cytokinetics	MYQORZO	aficamten	TABLET;ORAL	219083-003	Dec 19, 2025		RX	Yes	No	12,370,179					TREATMENT OF ADULTS WITH SYMPTOMATIC OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY (OHCM) TO IMPROVE FUNCTIONAL CAPACITY AND SYMPTOMS
Cytokinetics	MYQORZO	aficamten	TABLET;ORAL	219083-004	Dec 19, 2025		RX	Yes	No	12,370,179					TREATMENT OF ADULTS WITH SYMPTOMATIC OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY (OHCM) TO IMPROVE FUNCTIONAL CAPACITY AND SYMPTOMS

International Family Members for US Patent 12,370,179

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	126472
Australia	2022312506
Canada	3225787
Chile	2024000090
Chile	2024001945
China	117794535
Denmark	4370116